AQST
Aquestive Therapeutics Inc
4.60$
-1.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Aquestive Therapeutics Inc (AQST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -52 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.4 | -9.3 | -8.2 | 5.8 | -13 | -60 | -45 | -33 | -9.8 | -6.4 | -36 | -52 | |
| 0.7 | 1.7 | 3.9 | 3.8 | 3.2 | 2.9 | 3.4 | 3.0 | 2.4 | 1.3 | 0.7 | 0.5 | |
| – | – | – | – | 30 | 7.1 | 6.6 | 6.8 | 4.4 | 2.7 | 7.1 | 7.6 | |
| 0.8 | 1.2 | 5.2 | 3.6 | 35 | 12 | 6.8 | 20 | – | – | – | – | |
| – | – | -6.3 | 7.9 | 8.0 | -11 | -4.4 | -1.7 | 32 | -5.3 | -10.0 | 12 | |
| 2.8 | 3.4 | 1.0 | 2.1 | 1.8 | 0.7 | 0.5 | 0.9 | 2.5 | 1.0 | 0.2 | 0.6 | |
| -2.8 | -3.4 | 0.2 | -2.1 | -1.8 | -0.7 | -0.5 | -0.9 | -2.5 | -1.0 | -0.2 | -0.6 | |
| – | – | – | – | – | 2.8 | 0.1 | – | 0.0 | – | – | – | |
| 0.0 | 17 | 0.0 | 0.0 | 69 | -2.8 | -0.1 | 0.0 | 0.0 | 0.0 | – | – | |
| 10 | 9.7 | 7.5 | 5.0 | -4.8 | 13 | 22 | 0.0 | -2.0 | -22 | 0.0 | 0.0 | |
| 10 | 27 | 5.7 | 4.4 | 58 | 50 | 28 | 30 | 12 | 4.0 | 84 | 103 | |
| 1.1 | 14 | -2.3 | 8.2 | 43 | -11 | -18 | -3.8 | -0.8 | -3.4 | 48 | 50 | |
| – | – | -9.2 | 3.8 | -15 | -61 | -46 | -34 | -12 | -7.4 | -36 | -53 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.